ABEO
Abeona Therapeutics Inc
NASDAQ: ABEO · HEALTHCARE · BIOTECHNOLOGY
$5.34
-0.37% today
Updated 2026-04-29
Market cap
$303.75M
P/E ratio
5.29
P/S ratio
52.19x
EPS (TTM)
$1.01
Dividend yield
—
52W range
$4 – $8
Volume
1.2M
Abeona Therapeutics Inc (ABEO) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+71.4%
Last 4 quarters
Revenue YoY growth
+13.3%
Most recent quarter
EPS YoY growth
-15.6%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+3.0%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+8.6%
2025-11-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-23 | $-0.37 | -9.4% | $4.45 | $4.33 | -2.7% |
| 2025-11-12 | $-0.10 | +63.0% | $4.17 | $4.53 | +8.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.33 | $-0.37 | -9.4% | $5.42M | +13.3% |
| 2025-09-30 | $-0.27 | $-0.10 | +63.0% | — | — |
| 2025-06-30 | $-0.38 | $1.71 | +550.0% | $400000.00 | — |
| 2025-03-31 | $-0.35 | $-0.24 | +32.2% | — | — |
| 2024-12-31 | $-0.34 | $-0.32 | +8.0% | $4.78M | +69.3% |
| 2024-09-30 | $-0.40 | $-0.31 | +21.4% | — | — |
| 2024-06-30 | $-0.36 | $0.19 | +152.8% | — | — |
| 2024-03-31 | $-0.51 | $-1.16 | -127.5% | — | — |
| 2023-12-31 | $-0.47 | $-0.77 | -63.8% | $2.82M | — |
| 2023-09-30 | $-0.53 | $-0.48 | +9.4% | — | — |
| 2023-06-30 | $-0.68 | $-0.92 | -35.3% | $3.50M | — |
| 2023-03-31 | $-0.58 | $-0.54 | +6.9% | $68000.00 | — |
Frequently asked questions
Has Abeona Therapeutics Inc beaten earnings estimates?
Abeona Therapeutics Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +71.4% over the last 4 quarters.
How does ABEO stock react to earnings?
ABEO stock has moved an average of +3.0% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Abeona Therapeutics Inc's revenue growth rate?
Abeona Therapeutics Inc reported year-over-year revenue growth of +13.3% in its most recent quarter, with EPS growing -15.6% year-over-year.